{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "R1441C",
          "alt": "G2019S",
          "position": "1441C"
        },
        "variant_string_id": "EGFR R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations cause Parkinson's disease, and R1441C reduces Akt1 interaction.",
          "judgment": "Yes",
          "reasoning": "The paper directly links the mutation to Parkinson's disease and its mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity and protein interaction assays are standard for LRRK2 function.",
          "judgment": "Yes",
          "reasoning": "The assays used are widely accepted in the field.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type and mutant proteins are used as controls.",
          "judgment": "Yes",
          "reasoning": "Both normal and pathogenic variants are included in the studies.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No OddsPath calculation is provided, but the context supports pathogenicity.",
          "judgment": "Yes",
          "reasoning": "No direct OddsPath evidence, but the context indicates pathogenicity.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_very_strong",
        "strength": "PS3_very_strong",
        "overall_conclusion": "The mutation R1441C reduces Akt1 interaction, supporting pathogenicity. G2019S and I2020T show reduced phosphorylation, also supporting pathogenicity."
      }
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "G2019S",
          "alt": "I2020T",
          "position": "2019S"
        },
        "variant_string_id": "CFTR G2019S"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "CFTR mutations are associated with Parkinson's, and G2019S reduces Akt1 phosphorylation.",
          "judgment": "Yes",
          "reasoning": "The paper links the mutation to Parkinson's and its mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity and protein interaction assays are standard for CFTR function.",
          "judgment": "Yes",
          "reasoning": "The assays used are widely accepted in the field.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type and mutant proteins are used as controls.",
          "judgment": "Yes",
          "reasoning": "Both normal and pathogenic variants are included in the studies.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "BS3_moderate",
        "strength": "BS3_moderate",
        "overall_conclusion": "The mutation G2019S reduces Akt1 phosphorylation, supporting benignness. I2020T shows reduced phosphorylation, also supporting benignity."
      }
    }
  ]
}